x

Ocuphire Pharma, Inc. (Nasdaq:OCUP)

Health Care/Life Sciences • Pharmaceuticals
CIK 1228627
Company

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Address
37000 Grand River Avenue
Suite 120
Farmington Hills, Michigan 48335
Employees
9
Stock Info
Close
$2.4300
Day Range
2.3898 - 2.4740
52 Week Range
2.3400 - 6.6000
Average volume
209.6K
Short Interest
1.75M (02/15/24)
% of Float Shorted
7.86%
Market Cap
$59.43M
Revenue
$39.85M
Net Income
$17.89M
2020 Sales Growth
N/A
Rev. per Employee
$6.356M
P/E Ratio
1.85
EPS
$1.3153
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
George Magrath III, MD
Director
Jay S Pepose MD, PhD
Chairman
Cam S Gallagher MBA
Lead Independent Director
Sean Ainsworth MBA
Independent Director
James S. J Manuso PhD, MBA
Independent Director
Richard J Rodgers MBA, CPA
Independent Director
Susan K Benton MBA
SEC filings
DateFormEvent
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 8-K
30 May, 2024 DEFR14A
24 May, 2024 4
21 May, 2024 4
10 May, 2024 8-K
10 May, 2024 10-Q
10 May, 2024 8-K
29 Apr, 2024 DEFA14A
29 Apr, 2024 DEF 14A
29 Apr, 2024 ARS
19 Apr, 2024 PRE 14A
17 Apr, 2024 8-K
15 Apr, 2024 4
27 Mar, 2024 8-K
25 Mar, 2024 4
25 Mar, 2024 4
20 Mar, 2024 4
8 Mar, 2024 10-K
8 Mar, 2024 8-K
16 Feb, 2024 424B3
16 Feb, 2024 8-K
14 Feb, 2024 3
14 Feb, 2024 3
14 Feb, 2024 4
14 Feb, 2024 4
23 Jan, 2024 EFFECT
22 Jan, 2024 CORRESP
22 Jan, 2024 4
22 Jan, 2024 4
19 Jan, 2024 UPLOAD
12 Jan, 2024 4
12 Jan, 2024 4
12 Jan, 2024 4
11 Jan, 2024 S-8
10 Jan, 2024 S-3
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
6 Dec, 2023 8-K
5 Dec, 2023 4
27 Nov, 2023 3
27 Nov, 2023 4
27 Nov, 2023 8-K
21 Nov, 2023 S-8
13 Nov, 2023 8-K
13 Nov, 2023 4
13 Nov, 2023 4
13 Nov, 2023 10-Q
3 Nov, 2023 3
3 Nov, 2023 4
2 Nov, 2023 8-K
1 Nov, 2023 8-K CEO Change
27 Sep, 2023 8-K
14 Aug, 2023 424B5
11 Aug, 2023 8-K
11 Aug, 2023 10-Q
1 Aug, 2023 8-K
12 Jul, 2023 UPLOAD
7 Jul, 2023 CORRESP
28 Jun, 2023 UPLOAD
14 Jun, 2023 8-K
9 Jun, 2023 8-K
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
8 Jun, 2023 4
2 Jun, 2023 8-K
15 May, 2023 8-K
15 May, 2023 10-Q
1 May, 2023 DEF 14A
1 May, 2023 ARS
26 Apr, 2023 4
26 Apr, 2023 3
21 Apr, 2023 4
21 Apr, 2023 4
21 Apr, 2023 4
21 Apr, 2023 4
21 Apr, 2023 8-K CEO Change
5 Apr, 2023 S-8
30 Mar, 2023 10-K
30 Mar, 2023 8-K
14 Feb, 2023 5
14 Feb, 2023 5
14 Feb, 2023 SC 13G/A
25 Jan, 2023 8-K
12 Jan, 2023 4
12 Jan, 2023 4
12 Jan, 2023 4
12 Jan, 2023 4
12 Jan, 2023 4
12 Jan, 2023 4
12 Jan, 2023 4
6 Jan, 2023 4
6 Dec, 2022 8-K
7 Nov, 2022 8-K
4 Nov, 2022 10-Q
4 Nov, 2022 8-K
20 Oct, 2022 4
14 Oct, 2022 8-K
12 Oct, 2022 4
4 Oct, 2022 4
8 Sep, 2022 4
12 Aug, 2022 10-Q
12 Aug, 2022 8-K
6 Jul, 2022 4
6 Jul, 2022 4
6 Jul, 2022 4
6 Jul, 2022 4
17 Jun, 2022 8-K
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
10 Jun, 2022 8-K
10 Jun, 2022 DEFA14A
2 Jun, 2022 DEFA14A
24 May, 2022 4
23 May, 2022 4
19 May, 2022 8-K
17 May, 2022 SC 13G
13 May, 2022 8-K
13 May, 2022 10-Q
28 Apr, 2022 8-K
27 Apr, 2022 DEF 14A
27 Apr, 2022 DEFA14A
13 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 S-8
5 Apr, 2022 4
29 Mar, 2022 8-K
24 Mar, 2022 10-K
24 Mar, 2022 8-K
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 5
1 Feb, 2022 4
1 Feb, 2022 4
1 Feb, 2022 4
31 Jan, 2022 8-K
31 Jan, 2022 8-K
18 Jan, 2022 SC 13G/A
5 Jan, 2022 4
5 Jan, 2022 8-K
5 Jan, 2022 4
14 Dec, 2021 4
22 Nov, 2021 4
15 Nov, 2021 8-K
12 Nov, 2021 10-Q
4 Oct, 2021 4
4 Oct, 2021 4
15 Sep, 2021 4
3 Sep, 2021 4
12 Aug, 2021 8-K
12 Aug, 2021 10-Q
2 Jul, 2021 4
2 Jul, 2021 4
30 Jun, 2021 8-K
23 Jun, 2021 8-K
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 3
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 4
9 Jun, 2021 4
8 Jun, 2021 8-K
7 Jun, 2021 8-K/A
7 Jun, 2021 424B5
4 Jun, 2021 8-K
7 May, 2021 8-K
7 May, 2021 10-Q
26 Apr, 2021 DEFA14A
26 Apr, 2021 DEF 14A
12 Apr, 2021 8-K
5 Apr, 2021 4
5 Apr, 2021 4
31 Mar, 2021 S-8
26 Mar, 2021 SC 13G
17 Mar, 2021 SC 13G
15 Mar, 2021 8-K
11 Mar, 2021 424B5
11 Mar, 2021 8-K
11 Mar, 2021 8-K
11 Mar, 2021 10-K
17 Feb, 2021 424B4
16 Feb, 2021 SC 13G/A
12 Feb, 2021 EFFECT
11 Feb, 2021 CORRESP
11 Feb, 2021 S-3/A
10 Feb, 2021 UPLOAD
4 Feb, 2021 S-3
4 Feb, 2021 8-K
2 Feb, 2021 SC 13G/A
6 Jan, 2021 8-K
Last update:2024-03-06 12:31:21.809611
Ocuphire Pharma, Inc. by TradingView

Sign Up to Subscribe